We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

113 hedge funds and large institutions have $1.26B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2013 Q2 according to their latest regulatory filings, with 113 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more call options, than puts

Call options by funds: $74K | Put options by funds: $27K

Holders
113
Holders Change
+113
Holders Change %
% of All Funds
3.69%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
113
Increased
Reduced
Closed
Calls
$74K
Puts
$27K
Net Calls
+$47K
Net Calls Change
+$47K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

WX Hedge Fund Activity: Q2 2013 in Review

113 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q2 2013, worth a combined $1.26B.

Buyers outnumbered sellers: 113 funds opened new WX positions and 0 closed out — a net gain of 113 holders — while 0 added to existing stakes and 0 trimmed.

  • 113 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.26B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q2 2013.
  • 113 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q2 2013 and 0 closed out, a net change of +113 holders.

Based on aggregated 13F filings for Q2 2013.